Abstract
AbstractBackgroundMetabolic diseases, such as cardiovascular diseases and diabetes, contribute significantly to global mortality and disability. Wearable devices and smartphones increasingly track physiological and lifestyle risk factors and can improve the management of metabolic diseases. However, the absence of clear guidelines for deriving meaningful signals from these devices often hampers cross-study comparisons.ObjectiveThus, this scoping review protocol aims to systematically overview the current empirical literature on how wearables and smartphones are used to measure modifiable risk factors associated with metabolic diseases.MethodsWe will conduct a scoping review to overview how wearables and smartphones measure modifiable risk factors related to metabolic diseases. We will search six databases (Scopus, Web of Science, ScienceDirect, PubMed, ACM Digital Library, and IEEE Xplore) from 2019 to 2024, with search terms related to wearables, smartphones, and modifiable risk factors associated with metabolic diseases. We will apply the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) and Arksey and O’Malley’s scoping review methodology. Eligible studies will use smartphones and/or wearables (worn on the wrist, finger, arm, hip, and chest) to track physiological and/or lifestyle factors related to metabolic diseases. Two reviewers will independently screen articles for inclusion. Data will be extracted using a standardized form, and the findings will be synthesized and reported qualitatively and quantitatively.ResultsThe study is expected to identify potential gaps in measuring modifiable risk factors in current digital metabolic health research. Results are expected to inform more standardized guidelines on wearable and smartphone-based measurements to aid cross-study comparison. The final report is planned for submission to an indexed journal.ConclusionsThis review is among the first to systematically overview the current landscape on how wearables and smartphones are used to measure modifiable risk factors associated with metabolic diseases.
Publisher
Cold Spring Harbor Laboratory
Reference38 articles.
1. World Health Organization Noncommunicable Diseases: Mortality; 2023;
2. Bloom, D.E. ; Cafiero, E. ; Jané-Llopis, E. ; Abrahams-Gessel, S. ; Bloom, L.R. ; Fathima, S. ; Feigl, A.B. ; Gaziano, T. ; Hamandi, A. ; Mowafi, M. The Global Economic Burden of Noncommunicable Diseases; Program on the Global Demography of Aging, 2012;
3. The global burden of metabolic disease: Data from 2000 to 2019
4. Global Burden of Disease Collaborative Network Global Burden of Disease Study 2019 (GBD 2019); Seattle, United States, 2020;
5. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献